• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染对50岁以上人群社会护理使用情况的影响:伦敦西北部的一项配对队列研究

Impact of COVID-19 infection on social care use in people over 50 years of age: a matched cohort study in North-West London.

作者信息

Butfield Rebecca, Bray Benjamin, Quint Jennifer K, Castanon Alejandra, Adesanya Elizabeth, Chen Simon, Russell Rachel

机构信息

Pfizer Ltd, Sandwich, UK

Lane Clark & Peacock LLP, London, UK.

出版信息

BMJ Open. 2025 Jul 21;15(7):e100534. doi: 10.1136/bmjopen-2025-100534.

DOI:10.1136/bmjopen-2025-100534
PMID:40691022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12278131/
Abstract

OBJECTIVES

To estimate the impact of COVID-19 infection on the requirement for social care services among adults aged ≥50 years in North-West London.

DESIGN

Population-based matched cohort study using linked routinely collected electronic social care, primary care and hospital records (the Discover dataset).

SETTING

Approximately 4.7 million people with a general practitioner record in North-West London.

PARTICIPANTS

150 654 adults aged ≥50 years with a first diagnosis of COVID-19 between January 2020 and February 2023 and 547 704 propensity score matched comparators without a COVID-19 diagnosis during the same period.

MAIN OUTCOME MEASURES

Social care use and associated costs overall and by specific type (care home, domiciliary care, respite care, social care assessments) stratified by age group, index year, diagnosis setting, severe COVID-19 risk status, frailty and care home admission prior to index. Overall survival was also assessed.

RESULTS

A total of 9174 (6.09%) individuals with COVID-19 required social care use (of any type) during follow-up, 2.54 times (95% CI 2.48 to 2.61; p<0.0001) higher than matched comparators (n=13 126, 2.40%). The difference was largest for care home admission; individuals with COVID-19 had 4.10 (95% CI 3.87 to 4.36; p<0.0001) times the risk of a care home admission and nearly twice the risk (risk ratio 1.94; 95% CI 1.86 to 2.02; p<0.0001) of domiciliary care during follow-up compared with matched comparators. Individuals with COVID-19 experienced higher mortality, with 9.30% (14 005/547 704) dying during follow-up compared with 3.76% (20 608/547 704) deaths among matched comparators.This increase in social care utilisation was observed for all age groups. Adults with COVID-19 had over four times higher social care costs than matched comparators (£1276 per person per year (pppy) vs £276 pppy; mean difference +£1000, 95% CI £947 to £1054, p<0.0001), with most of the costs due to care home admissions. Higher social care costs in individuals with COVID-19 compared with matched comparators were strongly age related, rising from a mean difference of £130 pppy (95% CI £99 to £161) in those aged 50-64 to £6108 pppy (95% CI £5613 to £6603) higher costs in those aged ≥85.

CONCLUSIONS

COVID-19 infection is associated with meaningfully higher social care requirements in the ≥50 years population. Reducing the need for social care use and the associated costs of care should be one of the goals of interventions to reduce the risk and severity of COVID-19 infection.

摘要

目的

评估2019冠状病毒病(COVID-19)感染对伦敦西北部50岁及以上成年人社会护理服务需求的影响。

设计

基于人群的匹配队列研究,使用常规收集的电子社会护理、初级护理和医院记录相链接的数据(发现数据集)。

背景

伦敦西北部约有470万人有全科医生记录。

参与者

2020年1月至2023年2月期间首次诊断为COVID-19的150654名50岁及以上成年人,以及547704名倾向评分匹配的同期未诊断为COVID-19的对照者。

主要观察指标

按年龄组、索引年份、诊断地点、重症COVID-19风险状态、虚弱程度和索引前入住养老院情况分层的社会护理使用情况及相关费用,包括总体费用和特定类型(养老院护理、居家护理、临时护理、社会护理评估)的费用。还评估了总生存率。

结果

共有9174名(6.09%)COVID-19患者在随访期间需要使用社会护理服务(任何类型),是匹配对照者(n = 13126,2.40%)的2.54倍(95%CI 2.48至2.61;p<0.0001)。养老院入住差异最大;COVID-19患者入住养老院的风险是匹配对照者的4.10倍(95%CI 3.87至4.36;p<0.0001),随访期间接受居家护理的风险几乎是对照者的两倍(风险比1.94;95%CI 1.86至2.02;p<0.0001)。COVID-19患者的死亡率更高,随访期间死亡率为9.30%(14005/547704),而匹配对照者的死亡率为3.76%(20608/547704)。所有年龄组均观察到社会护理利用率的这种增加。COVID-19患者的社会护理费用比匹配对照者高出四倍多(每人每年1276英镑 vs 276英镑;平均差异+1000英镑;平均差异+1000英镑,95%CI 947至1054英镑,p<0.0001),大部分费用归因于养老院入住。与匹配对照者相比,COVID-19患者较高的社会护理费用与年龄密切相关,从50-64岁人群的平均差异130英镑(95%CI 99至161英镑)上升到85岁及以上人群的6108英镑(95%CI 5613至6603英镑)。

结论

COVID-19感染与50岁及以上人群中显著更高的社会护理需求相关。减少社会护理使用需求及相关护理费用应成为降低COVID-19感染风险和严重程度干预措施的目标之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/12278131/b2e9430b3a01/bmjopen-15-7-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/12278131/e716395fca20/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/12278131/b2e9430b3a01/bmjopen-15-7-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/12278131/e716395fca20/bmjopen-15-7-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f57b/12278131/b2e9430b3a01/bmjopen-15-7-g002.jpg

相似文献

1
Impact of COVID-19 infection on social care use in people over 50 years of age: a matched cohort study in North-West London.新冠病毒感染对50岁以上人群社会护理使用情况的影响:伦敦西北部的一项配对队列研究
BMJ Open. 2025 Jul 21;15(7):e100534. doi: 10.1136/bmjopen-2025-100534.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
4
Addressing Inequalities in Long Covid Healthcare: A Mixed-Methods Study on Building Inclusive Services.解决长期新冠医疗保健中的不平等问题:一项关于建立包容性服务的混合方法研究。
Health Expect. 2025 Aug;28(4):e70336. doi: 10.1111/hex.70336.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
7
Technology-enabled CONTACT tracing in care homes in the COVID-19 pandemic: the CONTACT non-randomised mixed-methods feasibility study.新冠疫情期间养老院中基于技术的接触者追踪:CONTACT非随机混合方法可行性研究
Health Technol Assess. 2025 May;29(24):1-24. doi: 10.3310/UHDN6497.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
10
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.

本文引用的文献

1
Social care data in the UK; current landscape, challenges, and future recommendations.英国社会关怀数据:现状、挑战与未来建议。
Expert Rev Pharmacoecon Outcomes Res. 2024 Feb;24(2):303-314. doi: 10.1080/14737167.2023.2274843. Epub 2024 Jan 25.
2
Persons diagnosed with COVID-19 in England in the Clinical Practice Research Datalink (CPRD): a cohort description.在英格兰临床实践研究数据库(CPRD)中诊断患有 COVID-19 的患者:队列描述。
BMJ Open. 2024 Jan 11;14(1):e073866. doi: 10.1136/bmjopen-2023-073866.
3
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study.
英格兰 COVID-19 成年患者的医疗资源利用情况以及住院和初级保健的费用:一项基于人群的队列研究。
BMJ Open. 2023 Dec 28;13(12):e075495. doi: 10.1136/bmjopen-2023-075495.
4
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
5
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19?虚弱和长新冠:COVID-19 是否导致因 COVID-19 住院而幸存的老年人虚弱状况发生转变?
Aging Clin Exp Res. 2023 Feb;35(2):455-461. doi: 10.1007/s40520-022-02308-4. Epub 2022 Nov 29.
6
Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.有 SARS-CoV-2 感染轻症或无症状病史患者的长期 COVID:一项全国性队列研究。
Scand J Prim Health Care. 2022 Sep;40(3):342-349. doi: 10.1080/02813432.2022.2139480. Epub 2022 Oct 31.
7
Frailty assessment for COVID-19 follow-up: a prospective cohort study.COVID-19 随访中的虚弱评估:一项前瞻性队列研究。
BMJ Open Respir Res. 2022 Apr;9(1). doi: 10.1136/bmjresp-2022-001227.
8
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.新冠病毒感染发病率、严重程度和死亡率的风险和保护因素。
Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19.
9
The impact of Covid-19, associated behaviours and policies on the UK economy: A computable general equilibrium model.新冠疫情、相关行为及政策对英国经济的影响:一个可计算一般均衡模型
SSM Popul Health. 2020 Dec;12:100651. doi: 10.1016/j.ssmph.2020.100651. Epub 2020 Oct 14.
10
Risk factors for Covid-19 severity and fatality: a structured literature review.Covid-19 严重程度和死亡率的风险因素:系统文献回顾。
Infection. 2021 Feb;49(1):15-28. doi: 10.1007/s15010-020-01509-1. Epub 2020 Aug 28.